Creative Medical Technology Holdings Inc (CELZ)

[swaddim]

Which CELZ will have a piece of. Look at the CEO's LinkedIn and see if you still believe there will be a buyout:

https://www.linkedin.com/in/timothy-warbington-90441150/

Contrary to many conventional biotechnology firms that may rely on the sale of intellectual property and patents as a financial exit strategy only after many years of clinical trials and subject to FDA approval, Creative Medical’s multifaceted business model, specific acquisitions and product development are intended to create a cash flow which shall provide an attractive return to its shareholders and provide the resources for expansion, acquisitions and development of cutting edge technology in the areas of stem cell technology and nutraceuticals.